Matthew Poli joins The Emerson Group
WAYNE, Pa. The Emerson Group on Thursday announced the addition of Matthew Poli to the company, effective Sept. 20. Poli’s responsibilities will include client business development, brand management and marketing. He will work out of Emerson’s Wayne, Pa., office and will report to Rick Wellinger, Emerson president.
Poli comes to Emerson with more than 16 years of experience in marketing, sales management, trade marketing and account development — all within Johnson & Johnson’s McNeil Consumer Healthcare unit. Most recently, Poli servied as senior brand manager of children’s Tylenol and children’s Motrin. In this P&L role, Poli was responsible for growing brand equity and market share, consumer communications and innovation pipeline development, Emerson noted.
In previous marketing roles, Poli developed the strategy extending Tylenol into the external pain-relief market, ultimately leading to the launch of Precise external pain relievers. Poli also launched Tylenol PM rapid-release gels in 2008.
“We are very excited about Matthew’s role in helping us achieve our goals we have established with our business partners,” Welllinger stated. “Please join me in welcoming Matthew, his wife Beth Ann and daughter Chelsea to The Emerson Group.”
MDA offers vouchers for free flu shots at Walgreens
SALT LAKE CITY Walgreens is teaming up with the Muscular Dystrophy Association to administer flu shots to those who need them most, according to published reports.
The MDA is handing out vouchers for free flu shots at Walgreens to those affected by muscular dystrophy and related diseases, according to ABC4News in Salt Lake City.
Voucher requests can be submitted here.
CBO: Generics saved $33 billion for Medicare Part D in 2007
WASHINGTON Generic drugs saved Medicare Part D beneficiaries and the program as a whole $33 billion in 2007, according to a new report by the nonpartisan Congressional Budget Office. The CBO expected another $14 billion in annual savings to accrue as many new generics enter the market through 2012.
The main lobby for pharmacy benefit managers said the report also showed the advantages of pharmacy benefit managers.
“Tools pioneered by pharmacy benefit managers — including encouraging the use of generic medications — have lowered costs and expanded access to prescription drugs for seniors in Medicare Part D,” Pharmaceutical Care Management Association president and CEO Mark Merritt said.
The generic drug industry lobby hailed the report as well. “This new CBO study is just one of a continued body of evidence proving that generics are a key cost-saving component of our healthcare system,” a statement by the Generic Pharmaceutical Association read.
According to the market research firm IMS Health, generic drugs accounted for nearly 75% of prescriptions dispensed in the United States, but for just more than 19% of dollars spent.